Acotiamide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| N-{2-[bis(1-methylethyl)amino]ethyl}-2-{[(2-hydroxy-4,5-dimethoxyphenyl)carbonyl]amino}-1,3-thiazole-4-carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Routes | Oral |
| Identifiers | |
| CAS number | 185106-16-5 |
| ATC code | None |
| PubChem | CID 5282338 |
| ChemSpider | 4445505 |
| UNII | D42OWK5383 |
| Chemical data | |
| Formula | C21H30N4O5S |
| Mol. mass | 450.55 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Acotiamide (YM-443, Z-338) is an experimental acetylcholinesterase inhibitor currently undergoing clinical trials for the treatment of functional dyspepsia.[1]
[edit] See also
[edit] References
- ^ Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H (January 2010). "Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage". Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society 22 (6): 618–e173. doi:10.1111/j.1365-2982.2009.01449.x. PMID 20059698.
|
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |

